Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
The purpose of this Notice of Funding Opportunity (NOFO) is to support SenNet Discovery and Validation Centers (SenNet DVCs) as a core component of Stage 2 of the NIH Common Fund Cellular Senescence Network (SenNet). Building on Stage 1 resources, DVCs will define, refine, and validate tissue- and disease-relevant cellular senescence signatures (“senotypes”) and associated biomarkers, and will investigate their functional consequences in human health and disease. DVCs are expected to generate and contribute high-quality molecular, cellular, and spatial datasets (including relevant metadata and documentation) and to use complementary experimental systems, as appropriate, to validate senotypes/biomarkers and characterize responses to senescence-associated perturbations or senotherapeutic approaches. DVC applications should also propose goals and aims for SenNet consortium-wide organizational and outreach activities (SenNet OOC functions).
Änderungsverlauf
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · 6069ced43be1
- 22 Oct 2026 · d8f0be444c14
- 21 Oct 2026 · 1de345e51fac
- 20 Oct 2026 · 4b2448af224d
- 19 Oct 2026 · bfa1f8391e97
- 18 Oct 2026 · b000e4e8d88b
- 17 Oct 2026 · 65592fbf3613
- 16 Oct 2026 · 2a6cb16ae2c3
- 15 Oct 2026 · eeb2b905ff89
- 14 Oct 2026 · 1ef8a55ce7ae
- 13 Oct 2026 · 8743d13d42f9
- 12 Oct 2026 · 83f83d3f4846
- 11 Oct 2026 · 7e7b6928c4bf
- 10 Oct 2026 · 2a0cf0ec0563
- 09 Oct 2026 · c8dabb0a3180
- 08 Oct 2026 · f906af495d1b
- 07 Oct 2026 · 78a9f81db48c
- 06 Oct 2026 · 74bdb861abe4
- 05 Oct 2026 · 9297802178b7
- 04 Oct 2026 · f28d8df7b991